第一项始终是图钉的来源。总体可信度是各份资料对上方所用开始和结束时间支持程度的加权平均;资料每比最新的一份旧 180 天,权重减半。
The release is datelined "ABBOTT PARK, Ill., and MADISON, Wis., Nov. 20, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) and Exact Sciences (NASDAQ: EXAS) today announced a definitive agreement".
MedTech Dive[4] analyst round-up: the largest medtech deal of the year and the largest under chief executive Robert Ford, about $100 million of pre-tax synergies expected by 2028.
Abbott's 8-K: the merger agreement was signed on 19 November 2025 at $105.00 in cash per share, conditional on Exact Sciences stockholder adoption and the Hart-Scott-Rodino waiting period.[1]
MedTech Dive's[2] same-day report: $105 a share, $1.8 billion of debt absorbed, the $60 billion segment by Abbott's estimate, and the year's largest medtech deal.
Chicago Tribune: a 51% premium to the $69.68 close on 18 November, Abbott's largest acquisition in a decade, and a 1.7% fall in Abbott shares that morning.[1]
有遗漏或错误吗?用你自己的话说明:能佐证此图钉的链接、不同的开始或结束日期及理由,或缺失、有误的信息。AI 会对照此图钉的来源进行核实,搜索更好的来源,并添加任何支持你说法的页面。图钉自身的来源仍然最重要。